Machine learning for medical imaging-based COVID-19 detection and diagnosis.
Rokaya RehoumaMichael BuchertYi-Ping Phoebe ChenPublished in: International journal of intelligent systems (2021)
The novel coronavirus disease 2019 (COVID-19) is considered to be a significant health challenge worldwide because of its rapid human-to-human transmission, leading to a rise in the number of infected people and deaths. The detection of COVID-19 at the earliest stage is therefore of paramount importance for controlling the pandemic spread and reducing the mortality rate. The real-time reverse transcription-polymerase chain reaction, the primary method of diagnosis for coronavirus infection, has a relatively high false negative rate while detecting early stage disease. Meanwhile, the manifestations of COVID-19, as seen through medical imaging methods such as computed tomography (CT), radiograph (X-ray), and ultrasound imaging, show individual characteristics that differ from those of healthy cases or other types of pneumonia. Machine learning (ML) applications for COVID-19 diagnosis, detection, and the assessment of disease severity based on medical imaging have gained considerable attention. Herein, we review the recent progress of ML in COVID-19 detection with a particular focus on ML models using CT and X-ray images published in high-ranking journals, including a discussion of the predominant features of medical imaging in patients with COVID-19. Deep Learning algorithms, particularly convolutional neural networks, have been utilized widely for image segmentation and classification to identify patients with COVID-19 and many ML modules have achieved remarkable predictive results using datasets with limited sample sizes.
Keyphrases
- coronavirus disease
- deep learning
- sars cov
- machine learning
- convolutional neural network
- high resolution
- computed tomography
- respiratory syndrome coronavirus
- loop mediated isothermal amplification
- healthcare
- artificial intelligence
- dual energy
- early stage
- endothelial cells
- label free
- big data
- public health
- image quality
- type diabetes
- contrast enhanced
- transcription factor
- rectal cancer
- positron emission tomography
- single cell
- radiation therapy
- mass spectrometry
- lymph node
- risk factors
- rna seq
- cardiovascular disease
- extracorporeal membrane oxygenation
- neoadjuvant chemotherapy
- locally advanced
- climate change